The Role of TP53 in Adaptation and Evolution

被引:43
作者
Voskarides, Konstantinos [1 ,2 ]
Giannopoulou, Nefeli [1 ]
机构
[1] Univ Nicosia, Med Sch, Dept Basic & Clin Sci, CY-2414 Nicosia, Cyprus
[2] Univ Nicosia, Sch Vet Med, CY-2414 Nicosia, Cyprus
关键词
oncogene; natural selection; environment; genetics; antagonistic pleiotropy; tumor; fitness; clonal expansion; animal model; phylogenetics; SUBTERRANEAN MOLE-RAT; ARG72PRO POLYMORPHISM; P53; PATHWAY; DNA-DAMAGE; CANCER; EXPRESSION; GENE; MUTATION; MUTANT; MICE;
D O I
10.3390/cells12030512
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The TP53 gene is a major player in cancer formation, and it is considered the most important tumor suppressor gene. The p53 protein acts as a transcription factor, and it is involved in DNA repair, senescence, cell-cycle control, autophagy, and apoptosis. Beyond cancer, there is evidence that TP53 is associated with fertility, aging, and longevity. Additionally, more evidence exists that genetic variants in TP53 are associated with environmental adaptation. Special TP53 amino-acid residues or pathogenic TP53 mutations seem to be adaptive for animals living in hypoxic and cold environments or having been exposed to starvation, respectively. At the somatic level, it has recently been proven that multiple cancer genes, including TP53, are under positive selection in healthy human tissues. It is not clear why these driver mutations do not transform these tissues into cancerous ones. Other studies have shown that elephants have multiple TP53 copies, probably this being the reason for the very low cancer incidence in these large animals. This may explain the famous Peto's paradox. This review discusses in detail the multilevel role of TP53 in adaptation, according to the published evidence. This role is complicated, and it extends from cells to individuals and to populations.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Identification of nonsynonymous TP53 mutations in hydatidiform moles
    Chan, Ka-Kui
    Wong, Esther Shuk-Ying
    Wong, Oscar Gee-Wan
    Ngan, Hextan Yuen-Sheung
    Cheung, Annie Nga-Yin
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2018, 809 : 20 - 23
  • [22] MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme
    Suh, Sung-Suk
    Yoo, Ji Young
    Nuovo, Gerard J.
    Jeon, Young-Jun
    Kim, Seokho
    Lee, Tae Jin
    Kim, Taewan
    Bakacs, Arianna
    Alder, Hansjuerg
    Kaur, Balveen
    Aqeilan, Rami I.
    Pichiorri, Flavia
    Croce, Carlo M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (14) : 5316 - 5321
  • [23] Germline mutation in the TP53 gene in uveal melanoma
    Hajkova, Nikola
    Hojny, Jan
    Nemejcova, Kristyna
    Dundr, Pavel
    Ulrych, Jan
    Jirsova, Katerina
    Glezgova, Johana
    Ticha, Ivana
    SCIENTIFIC REPORTS, 2018, 8
  • [24] TP53 and head and neck neoplasms
    Blons, H
    Laurent-Puig, P
    HUMAN MUTATION, 2003, 21 (03) : 252 - 257
  • [25] TP53 mutation in colorectal cancer
    Iacopetta, B
    HUMAN MUTATION, 2003, 21 (03) : 271 - 276
  • [26] Depicting the role of TP53 in hepatocellular carcinoma progression
    Villanueva, Augusto
    Hoshida, Yujin
    JOURNAL OF HEPATOLOGY, 2011, 55 (03) : 724 - 725
  • [27] TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
    Bouaoun, Liacine
    Sonkin, Dmitriy
    Ardin, Maude
    Hollstein, Monica
    Byrnes, Graham
    Zavadil, Jiri
    Olivier, Magali
    HUMAN MUTATION, 2016, 37 (09) : 865 - 876
  • [28] TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
    Wang, Haiwei
    Wang, Xinrui
    Xu, Liangpu
    Zhang, Ji
    BMC GENOMIC DATA, 2022, 23 (01):
  • [29] The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer
    Almquist, Lindsay M.
    Karagas, Margaret R.
    Christensen, Brock C.
    Welsh, Marleen M.
    Perry, Ann E.
    Storm, Craig A.
    Nelson, Heather H.
    CARCINOGENESIS, 2011, 32 (03) : 327 - 330
  • [30] TP53 mutation and survival in aggressive B cell lymphoma
    Zenz, Thorsten
    Kreuz, Markus
    Fuge, Maxi
    Klapper, Wolfram
    Horn, Heike
    Staiger, Annette M.
    Winter, Doris
    Helfrich, Hanne
    Huellein, Jennifer
    Hansmann, Martin-Leo
    Stein, Harald
    Feller, Alfred
    Moeller, Peter
    Schmitz, Norbert
    Truemper, Lorenz
    Loeffler, Markus
    Siebert, Reiner
    Rosenwald, Andreas
    Ott, German
    Pfreundschuh, Michael
    Stilgenbauer, Stephan
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (07) : 1381 - 1388